Publications and Mattias Ekstedt


Co-author map based on Web of Sciences articles 2007-

Publications mentioned in social media 86 times*

Journal Articles

Parambir S Dulai, Siddharth Singh, Janki Patel, Meera Soni, Larry J Prokop, Zobair Younossi, Giada Sebastiani, Mattias Ekstedt, Hannes Hagstrom, Patrik Nasr, Per Stal, Vincent Wai-Sun Wong, Stergios Kechagias, Rolf Hultcrantz and Rohit Loomba
  Increased risk of mortality by fibrosis stage in non-alcoholic fatty liver disease: Systematic Review and Meta-analysis.
  Hepatology, 2017, , .

Hannes Hagström, Patrik Nasr, Mattias Ekstedt, Stergios Kechagias, Kristina Onnerhag, Emma Nilsson, Fredrik Rorsman, Reza Sheikhi, Hanns-Ulrich Marschall, Rolf Hultcrantz and Per Stal
  Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease
  Scandinavian Journal of Gastroenterology, 2017, 52(2), 159-165.

Hannes Hagström, Patrik Nasr, Mattias Ekstedt, Stergios Kechagias, Per Stal, Pierre Bedossa and Rolf Hultcrantz
  SAF score and mortality in NAFLD after up to 41 years of follow-up
  Scandinavian Journal of Gastroenterology, 2017, 52(1), 87-91.

Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Mats Fredrikson, Per Stal, Stergios Kechagias and Rolf Hultcrantz
  Nonalcoholic Fatty Liver Disease Activity Score and Mortality: Imperfect But Not Insignificant REPLY
  Hepatology, 2016, 64(1), 310-311.

Patrik Nasr, Annette Hilliges, Lars Thorelius, Stergios Kechagias and Mattias Ekstedt
  Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease
  Scandinavian Journal of Gastroenterology, 2016, 51(9), 1126-1132.

Hannes Hagström, Patrik Nasr, Matteo Bottai, Mattias Ekstedt, Stergios Kechagias, Rolf Hultcrantz and Per Stål
  Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-up
  Liver international (Print), 2016, 36(11), 1688-1695.

Byron Lykiardopoulos, Hannes Hagström, Mats Fredrikson, Simone Ignatova, Per Stal, Rolf Hultcrantz, Mattias Ekstedt and Stergios Kechagias
  Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms
  PLoS ONE, 2016, 11(12), .
   Fulltext  PDF  

Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Mats Fredrikson, Per Stål, Stergios Kechagias and Rolf Hultcrantz
  Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
  Hepatology, 2015, 61(5), 1547-1554.
   Fulltext  PDF  
 Web of Science® Times Cited: 134

Christopher Sjöwall, Klara Martinsson, Kristina Cardell, Mattias Ekstedt and Stergios Kechagias
  Soluble urokinase plasminogen activator receptor levels are associated with severity of fibrosis in nonalcoholic fatty liver disease
  Translational research : the journal of laboratory and clinical medicine, 2015, 165(6), 658-666.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

Joel Johansson, Christofer Sahin, Rebecka Pestoff, Simone Ignatova, Pia Forsberg, Anders Edsjö, Mattias Ekstedt and Marie Stenmark Askmalm
  A Novel SMAD4 Mutation Causing Severe Juvenile Polyposis Syndrome with Protein Losing Enteropathy, Immunodeficiency, and Hereditary Haemorrhagic Telangiectasia.
  Case Reports in Gastrointestinal Medicine, 2015, 2015, 1-5.

Joel Johansson, Bergthor Björnsson, Simone Ignatova, Per Sandström and Mattias Ekstedt
  Littoral cell angioma in a patient with Crohn's disease.
  Case Reports in Gastrointestinal Medicine, 2015, 2015, 1-4.

G. Musso, R. Gambino, J.H. Tabibian, Mattias Ekstedt, Stergios Kechagias, M. Hamaguchi, R. Hultcrantz, H. Hagstrom, S.K. Yoon, P. Charatcharoenwitthaya, J. George, F. Barrera, S. Haflidadottir, E.S. Bjornsson, M.J. Armstrong, L.J. Hopkins, X. Gao, S. Francque, A. Verrijken, Y. Yilmaz, K.D. Lindor, M. Charlton, R. Haring, M.M. Lerch, R. Rettig, H. Volzke, S. Ryu, G. Li, L.L. Wong, M. Machado, H. Cortez-Pinto, K. Yasui and M. Cassader
  Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis
  PLoS Medicine, 2014, 11(7), e1001680.
   Fulltext  PDF  
 Web of Science® Times Cited: 56

Joel Johansson, Simone Ignatova and Mattias Ekstedt
  Pinworm infestation mimicking crohns' disease
  Case Reports in Gastrointestinal Medicine, 2013, 2013, .
   Fulltext  PDF  

Mattias Ekstedt, Lennart E Franzén, Ulrik L Mathiesen and Stergios Kechagias
  Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression
  Scandinavian Journal of Gastroenterology, 2012, 47(1), 108-115.
 Web of Science® Times Cited: 13

Christoffer Sjöwall, Kristina Cardell, Maria I Bokarewa, Helena Enocsson, Mattias Ekstedt, Liselott Lindvall, Aril Frydén and Sven Almer
  High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation
  Human Immunology, 2012, 73(4), 382-388.
   Fulltext  PDF  
 Web of Science® Times Cited: 8

E A Boström, Mattias Ekstedt, Stergios Kechagias, Christoffer Sjöwall, M I Bokarewa and Sven Almer
  Resistin is Associated with Breach of Tolerance and Anti-nuclear Antibodies in Patients with Hepatobiliary Inflammation
  Scandinavian Journal of Immunology, 2011, 74(5), 463-470.
   Fulltext  PDF  
 Web of Science® Times Cited: 7

Mattias Ekstedt, Lennart E Franzén, Marika Holmqvist, Preben Bendtsen, Ulrik L Mathiesen, Göran Bodemar and Stergios Kechagias
  Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease
  Scandinavian Journal of Gastroenterology, 2009, 44(3), 366-374.
 Web of Science® Times Cited: 40

Mattias Ekstedt, Lennart E. Franzén, Ulrik L. Mathiesen, Göran Bodemar and Stergios Kechagias
  The clinical relevance of the Nonalcoholic Fatty Liver Disease Activity Score (NAS) in predicting fibrosis progression
  , 2008, , .

Bengt Norén, Olof Dahlqvist Leinhard, Peter Lundberg, Sven Almer, Stergios Kechagias, Mattias Ekstedt, Lennart Franzén, Staffan Wirell and Örjan Smedby
  Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy
  European Journal of Radiology, 2008, 66(2), 313-320.
 Web of Science® Times Cited: 17

V Ratziu, E Bugianesi, J Dixon, E Fassio, Mattias Ekstedt, F Charlotte, Stergios Kechagias, T Poynard and R Olsson
  Histological progress of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability.
  Alimentary Pharmacology and Therapeutics, 2007, 26, 821-830.
 Web of Science® Times Cited: 40

Mattias Ekstedt, Lennart E Franzén, Ulrik L Mathiesen, Marika Holmqvist, Göran Bodemar and Stergios Kechagias
  Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study.
  Journal of Hepatology, 2007, 47(1), 135-141.
 Web of Science® Times Cited: 125

Mattias Ekstedt, Lennart E Franzén, Ulrik L Mathiesen, Lars Thorelius, Marika Holmqvist, Göran Bodemar and Stergios Kechagias
  Long-term follow-up of patients with NAFLD and elevated liver enzymes.
  Hepatology, 2006, 44(4), 865-873.
 Web of Science® Times Cited: 923

Lennart E Franzén, Mattias Ekstedt, Stergios Kechagias and Lennart Bodin
  Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting.
  Modern Pathology, 2005, 18(7), 912-916.
 Web of Science® Times Cited: 69

L. Franzen, Mattias Ekstedt, Stergios Kechagias, L. Bodin, R.N. Fiorini, J. Kirtz, B. Periyasamy, Z. Evans, J. Haines, G. Cheng, C. Polito, D. Rodwell, X. Zhou, C. Campbell, J. Birsner, M.G. Schmidt, D. Lewin and K.D. Chavin
  Letter to the editor (multiple letter)
  Clinical Transplantation, 2005, 19(4), 571.

Stergios Kechagias, Mattias Ekstedt, UL Mathiesen and L Franzen
  New reference interval for ALAT does not identify subclinical liver disease. Lower limit than the proposed should be used for medical considerations!
  Läkartidningen, 2004, 101, 2884-2887.

Chapters in Books

Annika Lindh Falk, Johanna Dahlberg, Mattias Ekstedt, Annika Heslyk, Per Whiss and Madeleine Abrandt Dahlgren
  Creating spaces for interprofessional learning: Strategic revision of a common IPL curriculum in undergraduate programs
  Interprofessional Education in Europe: Policy and Practice, Garant Publishers Limited, 2015, 49-66.


Conference Articles

Peter Lundberg, Mikael Forsgren, Patrik Nasr, Simone Ignatova, Olof Leinhard Dahlqvist, Nils Dahlström, Mattias Ekstedt and Stergios Kechagias
  Kvantifiering av leversteatos: diagnostisk utvärdering av protonmagnetresonansspektroskopi jämfört med histologiska metoder
  Gastrodagarna 11-13 maj 2016, Visby Sweden, 2016.


Peter Lundberg, Markus Karlsson, Mikael Forsgren, Nils Dahlström, Olof Leinhard Dahlqvist, Bengt Norén, Gunnar Cedersund, Mattias Ekstedt and Stergios Kechagias
  Mechanistic modeling of qDCE-MRI data reveals increased bile excretion of Gd-EOB-DTPA in diffuse liver disease patients with severe fibrosis
  ESMRMB 30 Sep - 1 Oct 2016, Vienna Austria, 2016.


Markus Karlsson, Mikael Forsgren, Nils Dahlström, Olof Leinhard Dahlqvist, Bengt Norén, Mattias Ekstedt, Stergios Kechagias and Peter Lundberg
  Diffuse Liver Disease: Measurements of Liver Trace Metal Concentrations and R2* Relaxation Rates
  ESMRMB 29 Sep - 1 Oct 2016, Vienna Austria, 2016.


Mikael Forsgren, Mattias Ekstedt, Olof Dahlqvist Leinhard, O. Andregård, Nils Dahlström, Stergios Kechagias, Sven Almer, Örjan Smedby, Peter Lundberg and Johan Kihlberg
  Prospective evaluation of liver steatosis comparing stereological point-counting biopsy analysis and 1H MRS
  ISMRM 20th Annual Meeting & Exhibition, 5-11 May, 2012, Melbourne, Australia, 2012.


* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.